NL-OMON35349已完成不适用
Clinical investigation of the safety of ALIMAXX-B biliary stent for bile duct obstruction - ALIMAXX-B* safety
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 13
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •a. Malignant obstructive disease at the level of the extrahepatic CBD
- •b. Willing and able to comply with study procedures and provide written informed consent
- •c. > 18 years of age presenting with biliary obstruction
排除标准
- •a. Benign obstruction of the CBD
- •b. Malignancy involving intrahepatic ducts or duodenum
- •c. Stricture >8cm in length
- •d. Prior bilairy metal stent
- •e Perforation of any duct within the biliary tree
- •f. Life expectancy of <90 days
- •g. Disease that is amenable to curative resection
- •h. INR > 1.5
- •i. Prior gastric bypass or biliroth type I or type II gastric resection
研究者
相似试验
已完成
不适用
Efficacy and tolerability of bixalomer for treatment of hyperphosphatemia in maintenance hemodialysis patients with poor tolerance to sevelamer: a switching study.Chronic renal failureJPRN-UMIN000010671Keijukai Healthcare Corporation,Saitama Tsukinomori Clinic50
进行中（未招募）
1 期
Evaluation of thesafety and efficacy of ambroxol in Gaucher disease caused by carrying the c.1448T>C mutation (p.Leu483Pro) and other rare variants of the GBA gene, based on clinical evaluation and results of genetic and metabolomic analysesGaucher diseaseEUCTR2021-006224-40-PLInstytut ,,Pomnik-Centrum Zdrowia Dziecka40
已完成
2 期
Study of Bavituximab plus Paclitaxel and Carboplatin in patients with Non small Cell Lung Cancer.CTRI/2008/091/000128Peregrine Pharmaceuticals, Inc49
已完成
2 期
The safety and efficacy trial of nab-paclitaxel and trastuzumab as neoadjuvant chemotherapy for HER2-positive breast cancerHER2-positive breast cancerJPRN-UMIN000012798Tokyo Medical University Ibaraki Medical Center35
已完成
Unknown
Hair oil study in evaluating increase in hair growth, hair volume.CTRI/2023/05/052846Transformative Learning Solutions Pvt Ltd33